The 'slimming elixir' has exceeded expectations! Novo Nordisk Q3 achieved record high revenue and profits
芊芊551
发表于 2023-11-2 17:37:49
245
0
0
On Thursday (November 2nd) local time, Danish pharmaceutical giant Novo Nordisk released its third quarter financial report, with record revenue and profit, and sales of the popular weight loss drug Wegovy exceeded expectations.
According to the financial report, Novo Nordisk Q3 sales amounted to 58.73 billion Danish kroner (approximately 8.34 billion US dollars), a year-on-year increase of 29%; The operating profit (EBIT) was DKK 26.91 billion (approximately USD 3.82 billion), a year-on-year increase of 33%; Both data exceeded market expectations.
(Source: Company website)
Wegovy, which is highly concerned by the market, had sales of DKK 9.648 billion (approximately $1.37 billion) in the third quarter, exceeding the market's expected DKK 8.07 billion.
Novo Nordisk stated in a statement that although Wegovy's supply capacity is gradually expanding, it will continue to restrict the supply of low-dose drugs in the United States to ensure the treatment of existing patients.
The company revealed that it had applied to US and EU authorities in September and October to approve Wegovy for reducing cardiovascular disease risk.
In August this year, Novo Nordisk stated that supply restrictions are likely to continue until 2024. Investors and analysts have asked the company to clarify when the supply issue can be resolved, as competitor Lilly expects its weight loss drug Mounjaro to receive US approval later this year.
Novo Nordisk's Wegovy and Lilly's Mounjaro are currently the most widely discussed weight loss drugs on the market, both of which belong to the new class of GLP-1 (glucagon like peptide-1) receptor agonists. Taking these GLP-1 drugs can lower blood sugar levels, increase satiety, and help control appetite and weight. In addition, Wegovy's "sisters product" and Ozempic, which is used to treat diabetes, have also attracted much attention.
Goldman Sachs released a forecast last month that by 2030, the annual sales of the global weight loss drug market may increase to around $100 billion, while Lilly and Novo Nordisk will form a duopoly, with these two pharmaceutical companies accounting for about 80% of the market share.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Netflix's revenue and profit in the third quarter exceeded expectations and rose by over 5% after the market closed
- TSMC's market value exceeds $1 trillion! Annual revenue expected to increase by 30%: AI demand is crazy and just beginning
- New Oriental: Expected net revenue of $851 million to $872 million in the second quarter of fiscal year 2025, up 25% -28% year-on-year
- Ford's revenue for the third quarter of this year was $46 billion, a year-on-year increase of 5%
- AMD's adjusted earnings per share for the third quarter met expectations, but its revenue outlook for the fourth quarter was not satisfactory
- AMD expects GPU sales to exceed $5 billion this year: Q4 revenue guidance falls short of expectations, market worries about AI demand
- Microsoft's first quarter revenue exceeded expectations
- Revenue and profit both decline, who is eating Nike's market
- Intel falls, AMD eats its fill! Wall Street predicts a significant decline in Intel's Q3 revenue
- Q4 revenue guidance falls short of expectations, Ideal US stock drops by over 13%, Li Xiang can still receive over 600 million yuan in equity incentives
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏